Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Crucell Acquiring Berna Biotech In US$449M All-Share Takeover

Dec. 2, 2005

By Cormac Sheridan

Pharmexa Raises $11.4M To Fund Acquisition From IDM

Nov. 30, 2005

By Cormac Sheridan

Actelion's Tracleer Falls Short In Pulmonary Fibrosis Studies

Nov. 30, 2005

By Cormac Sheridan

Actelion's Tracleer Falls Short In Pulmonary Fibrosis Studies

Nov. 30, 2005

By Cormac Sheridan

Pharmexa Raises $11.4M To Fund Acquisition From IDM

Nov. 30, 2005

By Cormac Sheridan

Nordic Biotechnology Group Emulating French Measures

Nov. 23, 2005

By Cormac Sheridan

Nordic Biotechnology Group Emulating French Measures

Nov. 23, 2005

By Cormac Sheridan

AM-Pharma Gets 9M In First Closing Of Series B Round

Nov. 2, 2005

By Cormac Sheridan

AM-Pharma Gets 9M In First Closing Of Series B Round

Nov. 2, 2005

By Cormac Sheridan

Biotec Pharmacon Raises NOK96M In Oslo Børs IPO

Oct. 26, 2005

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...